Citation: | CAO Zhen-xue, CUO Yuan-yuan, LIU Bei-bei, SUN Wei, GAO Wu-yue, LIANG Yu-jie, LIU Jian-min. Correlation analysis of mir-15a and postoperative recurrence amongst patients with bladder carcinoma[J]. Chinese Journal of General Practice, 2021, 19(4): 547-549, 647. doi: 10.16766/j.cnki.issn.1674-4152.001857 |
[1] |
李立强, 郭园园, 岳晓娥, 等. 二次等离子电切术在非肌层浸润性膀胱肿瘤中的应用[J]. 中华全科医学, 2020, 18(10): 1629-1632. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202010005.htm
|
[2] |
李利军, 马志伟, 龚百生, 等. 吉西他滨在高危非肌层浸润性膀胱癌二次电切术后的应用[J]. 现代医药卫生, 2016, 32(16): 2560-2561. doi: 10.3969/j.issn.1009-5519.2016.16.045
|
[3] |
CORREIA DE SOUSA M, GJORGJIEVA M, DOLICKA D, et al. Deciphering miRNAs' action through miRNA editing[J]. Int J Mol Sci, 2019, 20(24): 6249. doi: 10.3390/ijms20246249
|
[4] |
KABEKKODU S P, SHUKLA V, VARGHESE V K, et al. Clustered miRNAs and their role in biological functions and diseases[J]. Biol Rev Camb Philos Soc, 2018, 93(4): 1955-1986. doi: 10.1111/brv.12428
|
[5] |
SALIMINEJAD K, KHORRAM KHORSHID H R, SOLEYMANI FARD S, et al. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods[J]. J Cell Physiol, 2019, 234(5): 5451-5465. doi: 10.1002/jcp.27486
|
[6] |
JIN W, CHEN F, WANG K, et al. miR-15a/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-β signaling pathway[J]. Biomed Pharmacother, 2018, 104: 637-644. doi: 10.1016/j.biopha.2018.05.041
|
[7] |
BRAGA T V, EVANGELISTA F C G, GOMES L C, et al. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia[J]. Biomed Pharmacother, 2017, 92: 864-869. doi: 10.1016/j.biopha.2017.05.144
|
[8] |
GUO S, FESLER A, HUANG W, et al. Functional significance and therapeutic potential of mir-15a mimic in pancreatic ductal adenocarcinoma[J]. Mol Ther Nucleic Acids, 2020, 19: 228-239. doi: 10.1016/j.omtn.2019.11.010
|
[9] |
FAN B, CHEN L P, YUAN Y H, et al. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1[J]. Eur Rev Med Pharmacol Sci, 2019, 23(5): 1934-1946. http://www.ncbi.nlm.nih.gov/pubmed/30915736
|
[10] |
ZHANG J, ZHAO H, GAO Y, et al. Secretory miRNAs as novel cancer biomarkers[J]. Biochim Biophys Acta, 2012, 1826(1): 32-43. http://www.onacademic.com/detail/journal_1000035027968610_315c.html
|
[11] |
肖文杰, 崔德威. MicroRNA-146与肿瘤[J]. 中国临床研究, 2015, 28(11): 1519-1520, 1524. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK201511039.htm
|
[12] |
LIU D, ZHANG H, GE S, et al. Identification of HGF as a novel target of miR-15a/16/195 in gastric cancer[J]. Invest New Drugs, 2020, 38(4): 922-933. doi: 10.1007/s10637-019-00834-z
|
[13] |
LI Q, WANG H, PENG H, et al. MicroRNAs: key players in bladder cancer[J]. Mol Diagn Ther, 2019, 23(5): 579-601.
|
[14] |
TAHERI M, SHIRVANI-FARSANI Z, GHAFOURI-FARD S, et al. Expression profile of microRNAs in bladder cancer and their application as biomarkers[J]. Biomed Pharmacother, 2020, 131: 110703. doi: 10.1016/j.biopha.2020.110703
|
[15] |
JIA X, LIU H, XU C, et al. MiR-15a/16-1 deficiency induces IL-10-producing CD19 TIM-1 cells in tumor microenvironment[J]. J Cell Mol Med, 2019, 23(2): 1343-1353. doi: 10.1111/jcmm.14037
|
[16] |
LIU T, XU Z, OU D, et al. The miR-15a/16 gene cluster in human cancer: A systematic review[J]. J Cell Physiol, 2019, 234(5): 5496-5506. doi: 10.1002/jcp.27342
|
[17] |
WANG T, HOU J, LI Z, et al. MiR-15a-3p and miR-16-1-3p negatively regulate twist1 to repress gastric cancer cell invasion and metastasis[J]. Int J Biol Sci, 2017, 13(1): 122-134. doi: 10.7150/ijbs.14770
|
[18] |
LIU B, SUN T, WU G, et al. MiR-15a suppresses hepatocarcinoma cell migration and invasion by directly targeting[J]. Am J Transl Res, 2017, 9(2): 520-532. http://ajtr.org/files/ajtr0040269.pdf
|
[19] |
ZIDAN H E, ABDUL-MAKSOUD R S, ELSAYED W S H, et al. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer[J]. IUBMB Life, 2018, 70(5): 437-444. doi: 10.1002/iub.1733
|
[20] |
CUI Y, YANG Y, REN L, et al. miR-15a-3p Suppresses prostate cancer cell proliferation and invasion by targeting SLC39A7 via downregulating Wnt/β-Catenin signaling pathway[J]. Cancer Biother Radiopharm, 2019, 34(7): 472-479. doi: 10.1089/cbr.2018.2722
|